Presentation TCT 2012 Quality of Life: Should This Be the Key Parameter in Choosing Therapies? Presenter: John Spertus October 22, 2012
Presentation TCT 2012 Update on Important SFA Therapies: VIBRANT, VIPER and Zilver PTX Studies Presenter: Gary Ansel October 22, 2012
Presentation TCT 2012 Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro! Presenter: Gary Ansel October 22, 2012
Presentation TCT 2012 Impact of Stent Design on Outcomes After Bifurcation Stenting Presenter: Nicolas Foin October 22, 2012
Presentation TCT 2012 Importance of Sidebranch Closure After Bifurcation Stenting: When Should We Care? Presenter: Alexandra Lansky October 22, 2012
Presentation TCT 2012 STEMI Programs in the Middle East: Organization, Unique Challenges, and Results Presenter: Mohammed El Deeb October 22, 2012
Presentation TCT 2012 PC Trial Update: Late Breaking Trial Preview Presenter: Stephan Windecker October 22, 2012
Presentation TCT 2012 No: We Don't Need a Formal Scoring System, and We Know Complex Disease When We See It! Presenter: Jean Fajadet October 22, 2012
Presentation TCT 2012 BIOMATRIX: Final Five-Year LEADERS Results Presenter: Patrick Serruys October 22, 2012